Healthcare provider profile · identity verified

Cynthia M Williams, NP

Nurse Practitioner · MISHICOT, WI · NPI 1114034089

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	699	186
Amlodipine Besylate	Amlodipine Besylate	501	132
Levothyroxine Sodium	Levothyroxine Sodium	473	114
Lisinopril	Lisinopril	443	121
Omeprazole	Omeprazole	433	117
Losartan Potassium	Losartan Potassium	330	83
Rosuvastatin Calcium	Rosuvastatin Calcium	287	82
Metformin Hcl	Metformin Hcl	273	69
Alendronate Sodium	Alendronate Sodium	245	58
Metoprolol Succinate	Metoprolol Succinate	229	60
Metoprolol Tartrate	Metoprolol Tartrate	228	51
Pantoprazole Sodium	Pantoprazole Sodium	226	62
Hydrochlorothiazide	Hydrochlorothiazide	223	60
Simvastatin	Simvastatin	214	58
Furosemide	Furosemide	208	53
Gabapentin	Gabapentin	205	47
Sertraline Hcl	Sertraline Hcl	184	52
Buspirone Hcl	Buspirone Hcl	170	33
Eliquis	Apixaban	154	25
Albuterol Sulfate Hfa	Albuterol Sulfate	153	47
Spironolactone	Spironolactone	144	35
Meloxicam	Meloxicam	143	40
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	134	21
Pravastatin Sodium	Pravastatin Sodium	133	32
Glipizide Er	Glipizide	124	34
Trazodone Hcl	Trazodone Hcl	122	25
Potassium Chloride	Potassium Chloride	121	22
Allopurinol	Allopurinol	116	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	112	31
Glipizide	Glipizide	110	26
Warfarin Sodium	Warfarin Sodium	108	23
Clopidogrel	Clopidogrel Bisulfate	105	22
Famotidine	Famotidine	103	27
Citalopram Hbr	Citalopram Hydrobromide	99	26
Escitalopram Oxalate	Escitalopram Oxalate	97	29
Atenolol	Atenolol	96	20
Duloxetine Hcl	Duloxetine Hcl	94	21
Metformin Hcl Er	Metformin Hcl	94	26
Ozempic	Semaglutide	92	15
Fluoxetine Hcl	Fluoxetine Hcl	86	18
Montelukast Sodium	Montelukast Sodium	84	21
Tamsulosin Hcl	Tamsulosin Hcl	80	21
Fluticasone Propionate	Fluticasone Propionate	77	30
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	18
Synthroid	Levothyroxine Sodium	66	14
Alprazolam	Alprazolam	65	14
Lovastatin	Lovastatin	61	16
Valsartan	Valsartan	57	14
Propranolol Hcl	Propranolol Hcl	56	16
Tizanidine Hcl	Tizanidine Hcl	56	27
Amitriptyline Hcl	Amitriptyline Hcl	53	11
Bupropion Xl	Bupropion Hcl	53	12
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Cephalexin	Cephalexin	48	40
Januvia	Sitagliptin Phosphate	47	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	suppressed
Bupropion Hcl Sr	Bupropion Hcl	41	suppressed
Jardiance	Empagliflozin	41	suppressed
Mirtazapine	Mirtazapine	41	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Amoxicillin	Amoxicillin	34	22
Baclofen	Baclofen	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	13
Pregabalin	Pregabalin	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	26
Carvedilol	Carvedilol	30	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	12
Verapamil Er	Verapamil Hcl	25	suppressed
Lorazepam	Lorazepam	23	11
Topiramate	Topiramate	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Nystatin	Nystatin	21	16
Nifedipine Er	Nifedipine	20	suppressed
Prednisone	Prednisone	20	13
Xarelto	Rivaroxaban	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Hydroxyzine Hcl	Hydroxyzine Hcl	19	11
Nyamyc	Nystatin	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	12
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Fluconazole	Fluconazole	17	12
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	13
Estradiol	Estradiol	16	suppressed
Tiotropium Bromide	Tiotropium Bromide	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Unifine Pentips Plus	Pen Needle, Diabetic	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Finasteride	Finasteride	15	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Methylprednisolone	Methylprednisolone	13	12
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Estarylla	Norgestimate-Ethinyl Estradiol	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error